HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-coding RNAs in cardiovascular cell biology and atherosclerosis.

Abstract
Atherosclerosis underlies the predominant number of cardiovascular diseases and remains a leading cause of morbidity and mortality worldwide. The development, progression and formation of clinically relevant atherosclerotic plaques involves the interaction of distinct and over-lapping mechanisms which dictate the roles and actions of multiple resident and recruited cell types including endothelial cells, vascular smooth muscle cells, and monocyte/macrophages. The discovery of non-coding RNAs (ncRNAs) including microRNAs, long non-coding RNAs, and circular RNAs, and their identification as key mechanistic regulators of mRNA and protein expression has piqued interest in their potential contribution to atherosclerosis. Accruing evidence has revealed ncRNAs regulate pivotal cellular and molecular processes during all stages of atherosclerosis including cell invasion, growth, and survival; cellular uptake and efflux of lipids, expression and release of pro- and anti-inflammatory intermediaries, and proteolytic balance. The expression profile of ncRNAs within atherosclerotic lesions and the circulation have been determined with the aim of identifying individual or clusters of ncRNAs which may be viable therapeutic targets alongside deployment as biomarkers of atherosclerotic plaque progression. Consequently, numerous in vivo studies have been convened to determine the effects of moderating the function or expression of select ncRNAs in well-characterized animal models of atherosclerosis. Together, clinicopathological findings and studies in animal models have elucidated the multifaceted and frequently divergent effects ncRNAs impose both directly and indirectly on the formation and progression of atherosclerosis. From these findings' potential novel therapeutic targets and strategies have been discovered which may pave the way for further translational studies and possibly taken forward for clinical application.
AuthorsFrancesca Fasolo, Karina Di Gregoli, Lars Maegdefessel, Jason L Johnson
JournalCardiovascular research (Cardiovasc Res) Vol. 115 Issue 12 Pg. 1732-1756 (10 01 2019) ISSN: 1755-3245 [Electronic] England
PMID31389987 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
CopyrightPublished on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: [email protected].
Chemical References
  • MicroRNAs
  • RNA, Circular
  • RNA, Long Noncoding
  • RNA, Untranslated
Topics
  • Animals
  • Arteries (metabolism, pathology)
  • Atherosclerosis (genetics, metabolism, pathology)
  • Endothelial Cells (metabolism, pathology)
  • Gene Expression Regulation
  • Humans
  • MicroRNAs (genetics, metabolism)
  • Myocytes, Smooth Muscle (metabolism, pathology)
  • Plaque, Atherosclerotic
  • RNA, Circular (genetics, metabolism)
  • RNA, Long Noncoding (genetics, metabolism)
  • RNA, Untranslated (genetics, metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: